Deucravacitinib in Moderate to Severe Psoriasis : Clinical and Quality-of-Life Outcomes in a Phase 2 Trial
-
Thaçi, Diamant (University of Luebeck)
;
Strober, Bruce (Yale University) ;
Gordon, Kenneth B. (Medical College of Wisconsin) ;
Foley, Peter (The University of Melbourne) ;
Gooderham, Melinda (Queen's University and Probity Medical Research) ;
Morita, Akimichi (Nagoya City University) ;
Papp, Kim A. (Clinical Research and Probity Medical Research) ;
Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ;
Menter, M. Alan (Baylor University Medical Center) ;
Colombo, Matthew J. (Bristol Myers Squibb) ;
Elbez, Yedid (Bristol Myers Squibb) ;
Kisa, Renata M. (Bristol Myers Squibb) ;
Ye, June (Bristol Myers Squibb) ;
Napoli, Andrew A. (Bristol Myers Squibb) ;
Wei, Lan (Bristol Myers Squibb) ;
Banerjee, Subhashis (Bristol Myers Squibb) ;
Merola, Joseph F. (Harvard Medical School) ;
Gottlieb, Alice B. (Icahn School of Medicine at Mount Sinai) ;
Universitat Autònoma de Barcelona
visitante ::
identificación
Subscribirse to this discussion. You will then receive all new comments by email.
